Case Reports

Recurrent Varicella in an Immunocompetent Woman

Author and Disclosure Information

Varicella-zoster virus (VZV) infection causes 2 distinct disease processes. Primary VZV infection results in varicella (chickenpox), a common generalized eruption, and subsequent reactivation of VZV classically results in herpes zoster (shingles), which presents as a unilateral, dermatomal eruption. Although a single VZV infection typically confers protection against its reactivation, recurrent varicella rarely is reported, particularly in immunocompetent patients. We present the case of a 52-year-old black woman with an intact immune system who demonstrated 3 VZV infections.

Practice Points

  • Varicella is a viral exanthem that manifests as generalized and pruritic papules, vesicles, and crusted lesions and is the initial expression of infection with the varicella-zoster virus (VZV).
  • Secondary expression of VZV infection is typified by herpes zoster, where painful papules and vesicles are confined within a single dermatome.
  • Although contradictory to dogma and public perception, varicella may occur more than once; therefore, patients with a generalized pruritic exanthem should be screened for varicella, even if they report a history of varicella.


 

References

Case Report

A 52-year-old black woman presented to our dermatology clinic for evaluation of a generalized pruritic rash of 5 days’ duration. The eruption had started on the trunk and subsequently spread to the face, legs, and arms, including the dorsal surfaces of the hands (Figure 1). The patient reported that she had developed a similar rash 4 years prior. She recalled no sick contacts but had occupational exposure to many people as a food service worker. Two days prior, the referring physician had initiated treatment with oral acyclovir 400 mg every 6 hours. The patient was in otherwise good health and reported no fever, chills, diaphoresis, or fatigue. She did not recall any recent insect bites, and a review of systems was negative.

Figure 1. Papules, vesicles, and crusts on the dorsal surfaces of both hands in a 52-year-old black woman.

Figure 1. Papules, vesicles, and crusts on the dorsal surfaces of both hands in a 52-year-old black woman.

The patient’s medical history was remarkable for 2 cases of varicella: the first, which occurred at 5 years of age, was diagnosed by a pediatrician and manifested as diffuse papules, vesicles, and crusts with concurrent mild fever. The infection followed a typical clinical course and resolved without complications after 1 week. The second case of varicella was diagnosed clinically at our dermatology clinic approximately 4 years prior to the current presentation and manifested as widespread pruritic lesions that were too numerous to count. Given her history of varicella in childhood, a punch biopsy specimen was taken from a lesion on the left trunk and a dermatopathologist confirmed the diagnosis of a herpesvirus infection. The second infection also resolved without sequelae after 12 days. Her medical history was otherwise unremarkable, revealing no exceptional sinopulmonary or gastrointestinal infections. The patient was not currently taking any medications or supplements and reported no known drug allergies.

Physical examination at the current presentation revealed a well-nourished, afebrile woman with vesicles and papules on the hands, arms, and legs along with vesicular and crusted papules in various stages of healing distributed on the chest, abdomen, and back. Lesions on the legs and feet were present but scant. The eruption was not confined to a single dermatome. No lesions were noted on the palms, soles, or oral mucosa and no epitrochlear, axillary, or supraclavicular lymphadenopathy was noted.

Initial laboratory values were obtained. A complete blood count demonstrated a normal leukocyte number of 5700 cells/μL (reference range, 4500–11,000 cells/μL) and mild anemia with a hemoglobin level of 10.3 g/dL (reference range, 14.0–17.5 g/dL). Monocytes were mildly elevated at 11% (reference range, 1%–9%). Serologic tests showed positive titers for varicella-zoster virus (VZV) IgM at 1.64 (negative, <0.91) and VZV IgG at 1.72 (negative, <0.91), indicating current and past VZV infection, respectively. Antibodies against herpes simplex virus (HSV) types 1 and 2 were negative for IgM and positive for IgG at >5.00 (negative, <0.90), indicating a remote HSV infection. Furthermore, results from a culture of a lesion on the left hand were negative for HSV.

After consultation with the Department of Infectious Diseases, further laboratory studies were performed. The absolute lymphocyte number was within normal range at 1600 cells/μL (reference range, 850–3900 cells/μL). Likewise, CD4+ T lymphocytes were normal at 618 cells/μL (reference range, 490–1740 cells/μL) or 39% of total lymphocytes (reference range, 30%–61%). Screening results were negative for human immunodeficiency virus types 1 and 2. Immunoglobulin subtype analysis revealed slightly elevated IgG at 1709 mg/dL (reference range, 723–1685 mg/dL), elevated IgA at 487 mg/dL (reference range, 65–382 mg/dL), and normal IgM at 238 mg/dL (reference range, 63–277 mg/dL).

Consistent with the clinical presentation and serologic studies, recurrent varicella was accepted as the most plausible diagnosis. Over the next 2 weeks, the eruption resolved with postinflammatory hyperpigmentation (Figure 2). The patient returned to work without further incident.

Figure 2. Lesions on the back that resolved after 2 weeks with postinflammatory hyperpigmentation.

Figure 2. Lesions on the back that resolved after 2 weeks with postinflammatory hyperpigmentation.

Pages

Recommended Reading

Purpura Fulminans in the Setting of Escherichia coli Septicemia
MDedge Dermatology
USPSTF continues to urge syphilis screening in high-risk groups
MDedge Dermatology
Early infection-related hospitalization portends poor breast cancer prognosis
MDedge Dermatology
What Is Your Diagnosis? Herpes Zoster
MDedge Dermatology
Chagas disease: Neither foreign nor untreatable
MDedge Dermatology
WHO identifies top emerging diseases
MDedge Dermatology
Second dose of herpes zoster vaccine beneficial to seniors
MDedge Dermatology
Testing, early antiretroviral treatment could slash HIV infection rate in men
MDedge Dermatology
Oral fluconazole raises miscarriage risk
MDedge Dermatology
Novel treatments assessed in midst of Ebola crisis
MDedge Dermatology